Good milestone reached but a long way from the end goal of FDA approval. FDA will certainly ask for another study which will take MSB about 6 months to recruit, a 12 months minimum to potentially 24 months of study time requiring mighty patience required from all stakeholders, shareholders included. Thats 2.5 years for this to go anywhere forward.
Chartically will be a red open to close candle in the price charts for the day. The surge of this announcement will subside over the next few days as it has with prior similar announcements. This is a long term journey. shorters make millions, we hardcore optimistic shareholders will hang on.
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-111
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |